ClariTrial | Search Clinical Trials

Explore/HIV Infections

Status

Phase

11,989 results for “HIV Infections”

Page 1 of 800

Completed

Spirituality and Will to Live in Patients With HIV/AIDS

N/AHIV Infections

National Center for Complementary and Integrative Health (NCCIH)350 participants1 site · United States

Compare CT.gov Full analysis →

Terminated

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

Phase 1HIV Infections

NevirapineAmprenavirAbacavir

Boehringer Ingelheim8 participantsCompletes Jul 2001

Compare CT.gov Full analysis →

Completed

Results posted

Care4Today v2.0 Application for Improving Adherence to HIV Medications

N/AHIVAIDS

Care4Today v2.0 mobile application + electronic monitoring of adherence

University of California, San Diego60 participants1 site · United StatesCompletes Oct 2014

Compare CT.gov Full analysis →

Recruiting

Evaluation of Intermittent Triple Therapies in Real Life

N/AHIV Infections

University Hospital, Strasbourg, France200 participants1 site · FranceCompletes Feb 2025

Compare CT.gov Full analysis →

Completed

Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU

N/AHIV

Individual levelStructural levelIndividual level standard of care+1 more

Johns Hopkins Bloomberg School of Public Health2,175 participants1 site · VietnamCompletes Apr 2013

Compare CT.gov Full analysis →

Completed

Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma

Phase 2Lymphoma

filgrastimrecombinant interleukin-12etoposide+1 more

National Cancer Institute (NCI)40 participants10 sites · United StatesCompletes Apr 2002

Compare CT.gov Full analysis →

Completed

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Phase 1HIV Infections

fosamprenavir/ritonavirolanzapineolanzapine

Radboud University Medical Center24 participants1 site · NetherlandsCompletes Aug 2010

Compare CT.gov Full analysis →

Completed

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Phase 2Hiv

Romidepsin3BNC117Antiretrovirals

Aarhus University Hospital60 participants7 sites · Denmark, United KingdomCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Phase 3MalariaHIV/AIDSPregnancy Related

Dihydroartemisinin-piperaquine (DHA-PPQ)Placebo Oral Tablet

Barcelona Institute for Global Health666 participants2 sites · Gabon, MozambiqueCompletes Jul 2022

Compare CT.gov Full analysis →

UNKNOWN

Kumasi Cohort Study

N/AHIV

Virological monitoring

Bernhard Nocht Institute for Tropical Medicine3,000 participants1 site · GhanaCompletes Jun 2021

Compare CT.gov Full analysis →

Completed

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Phase 3HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection

Eutrophill

Assistance Publique - Hôpitaux de Paris100 participants1 site · FranceCompletes Jul 2008

Compare CT.gov Full analysis →

Completed

Results posted

The Safety and Immunogenicity of a Potential HIV Vaccine

Phase 1HIV Infections

CN54gp140 mixed with GLA-AF

Imperial College London14 participants1 site · United KingdomCompletes Nov 2015

Compare CT.gov Full analysis →

Completed

Results posted

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

N/ATuberculosisNon-tuberculous Mycobacterial Diseases (Including MAC Disease)

rifabutin

Pfizer628 participantsCompletes Jul 2016

Compare CT.gov Full analysis →

UNKNOWN

Exercise for Patients With HIV Infections

Phase 2Phase 3HIV InfectionsLipodystrophyInflammation

Exercise

Charite University, Berlin, Germany60 participants1 site · GermanyCompletes Jan 2010

Compare CT.gov Full analysis →

Completed

A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers

Phase 2HIV Infections

MN rgp120/HIV-1 and GNE8 rgp120/HIV-1MN rgp120/HIV-1 and A244 rgp120/HIV-1ALVAC-HIV MN120TMG (vCP205)+1 more

National Institute of Allergy and Infectious Diseases (NIAID)420 participants18 sites · United States

Compare CT.gov Full analysis →

1–15 of 11,989

Explore/HIV Infections

Status

Phase

11,989 results for “HIV Infections”

Page 1 of 800

Completed

Spirituality and Will to Live in Patients With HIV/AIDS

N/AHIV Infections

National Center for Complementary and Integrative Health (NCCIH)350 participants1 site · United States

Compare CT.gov Full analysis →

Terminated

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

Phase 1HIV Infections

NevirapineAmprenavirAbacavir

Boehringer Ingelheim8 participantsCompletes Jul 2001

Compare CT.gov Full analysis →

Completed

Results posted

Care4Today v2.0 Application for Improving Adherence to HIV Medications

N/AHIVAIDS

Care4Today v2.0 mobile application + electronic monitoring of adherence

University of California, San Diego60 participants1 site · United StatesCompletes Oct 2014

Compare CT.gov Full analysis →

Recruiting

Evaluation of Intermittent Triple Therapies in Real Life

N/AHIV Infections

University Hospital, Strasbourg, France200 participants1 site · FranceCompletes Feb 2025

Compare CT.gov Full analysis →

Completed

Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU

N/AHIV

Individual levelStructural levelIndividual level standard of care+1 more

Johns Hopkins Bloomberg School of Public Health2,175 participants1 site · VietnamCompletes Apr 2013

Compare CT.gov Full analysis →

Completed

Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma

Phase 2Lymphoma

filgrastimrecombinant interleukin-12etoposide+1 more

National Cancer Institute (NCI)40 participants10 sites · United StatesCompletes Apr 2002

Compare CT.gov Full analysis →

Completed

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Phase 1HIV Infections

fosamprenavir/ritonavirolanzapineolanzapine

Radboud University Medical Center24 participants1 site · NetherlandsCompletes Aug 2010

Compare CT.gov Full analysis →

Completed

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Phase 2Hiv

Romidepsin3BNC117Antiretrovirals

Aarhus University Hospital60 participants7 sites · Denmark, United KingdomCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Phase 3MalariaHIV/AIDSPregnancy Related

Dihydroartemisinin-piperaquine (DHA-PPQ)Placebo Oral Tablet

Barcelona Institute for Global Health666 participants2 sites · Gabon, MozambiqueCompletes Jul 2022

Compare CT.gov Full analysis →

UNKNOWN

Kumasi Cohort Study

N/AHIV

Virological monitoring

Bernhard Nocht Institute for Tropical Medicine3,000 participants1 site · GhanaCompletes Jun 2021

Compare CT.gov Full analysis →

Completed

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Phase 3HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection

Eutrophill

Assistance Publique - Hôpitaux de Paris100 participants1 site · FranceCompletes Jul 2008

Compare CT.gov Full analysis →

Completed

Results posted

The Safety and Immunogenicity of a Potential HIV Vaccine

Phase 1HIV Infections

CN54gp140 mixed with GLA-AF

Imperial College London14 participants1 site · United KingdomCompletes Nov 2015

Compare CT.gov Full analysis →

Completed

Results posted

Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

N/ATuberculosisNon-tuberculous Mycobacterial Diseases (Including MAC Disease)

rifabutin

Pfizer628 participantsCompletes Jul 2016

Compare CT.gov Full analysis →

UNKNOWN

Exercise for Patients With HIV Infections

Phase 2Phase 3HIV InfectionsLipodystrophyInflammation

Exercise

Charite University, Berlin, Germany60 participants1 site · GermanyCompletes Jan 2010

Compare CT.gov Full analysis →

Completed

A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers

Phase 2HIV Infections

MN rgp120/HIV-1 and GNE8 rgp120/HIV-1MN rgp120/HIV-1 and A244 rgp120/HIV-1ALVAC-HIV MN120TMG (vCP205)+1 more

National Institute of Allergy and Infectious Diseases (NIAID)420 participants18 sites · United States

Compare CT.gov Full analysis →

1–15 of 11,989